Journal of Lipid Research, Vol 38, 1822-1832, Copyright © 1997 by Lipid Research, Inc.

ARTICLES

Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice

KA Dugi, BL Vaisman, N Sakai, CL Knapper, SM Meyn, HB Brewer Jr and S Santamarina- Fojo
Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

In order to evaluate the coordinate role that hepatic lipase (HL) and lecithin:cholesterol acyltransferase (LCAT) play in modulating HDL particle heterogeneity and function in vivo we utilized recombinant adenovirus to express HL in control and LCAT transgenic mice. Adenovirus-mediated expression of human HL in control (n = 4, LCAT activity = 42 +/- 1 nmol/ml per h) and LCAT-tg mice (n = 4, LCAT activity = 3566 +/- 93 nmol/ml per h) resulted in post heparin HL activities of 24,358 +/- 6080 and 27,266 +/- 7985 nmol/ml per min, respectively. Overexpression of HL led to significant reductions in total cholesterol, phospholipids, and HDL cholesterol in both LCAT-tg (62, 62, and 63%, P < 0.05) and control mice (68, 63, and 78%, P < 0.01) as well as to the formation of more homogenous HDL. However, compared to control animals, the reductions in the plasma concentrations of HDL-cholesterol and apoA-I were less in LCAT-tg mice (HDL-cholesterol: -62 +/- 15% vs. -78 +/- 15%, P = 0.18; apoA-I: -36 +/- 7% vs. -76 +/- 8%, P < 0.0005). Gel filtration analysis revealed that in LCAT-tg mice the apoE-rich HDL1 was preferentially reduced by expression of HL in vivo. Compared to control mice the reduction in the apoA-I/A-II HDL in transgenic mice was significantly less indicating that a subset of HDL in LCAT transgenic mice are resistant to the action of HL. These combined data support a role for both HL and LCAT in modulating HDL heterogeneity and function, properties which may ultimately affect the ability of LCAT transgenic mouse HDL to function in the process of reverse cholesterol transport.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Maugeais, U. J.F. Tietge, U. C. Broedl, D. Marchadier, W. Cain, M. G. McCoy, S. Lund-Katz, J. M. Glick, and D. J. Rader Dose-Dependent Acceleration of High-Density Lipoprotein Catabolism by Endothelial Lipase Circulation, October 28, 2003; 108(17): 2121 - 2126. [Abstract] [Full Text] [PDF]

				U. C. Broedl, C. Maugeais, D. Marchadier, J. M. Glick, and D. J. Rader Effects of Nonlipolytic Ligand Function of Endothelial Lipase on High Density Lipoprotein Metabolism in Vivo J. Biol. Chem., October 17, 2003; 278(42): 40688 - 40693. [Abstract] [Full Text] [PDF]

				G. Lambert, M. J. A. Amar, P. Martin, J. Fruchart-Najib, B. Föger, R. D. Shamburek, H. B. Brewer , Jr., and S. Santamarina-Fojo Hepatic lipase deficiency decreases the selective uptake of HDL-cholesteryl esters in vivo J. Lipid Res., May 1, 2000; 41(5): 667 - 672. [Abstract] [Full Text]

				K. A. Dugi, M. J. A. Amar, C. C. Haudenschild, R. D. Shamburek, A. Bensadoun, R. F. Hoyt Jr, J. Fruchart-Najib, Z. Madj, H. B. Brewer Jr, and S. Santamarina-Fojo In Vivo Evidence for Both Lipolytic and Nonlipolytic Function of Hepatic Lipase in the Metabolism of HDL Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 793 - 800. [Abstract] [Full Text] [PDF]

				P. Holvoet, B. De Geest, S. Van Linthout, M. Lox, S. Danloy, K. Raes, and D. Collen The Arg123-Tyr166 Central Domain of Human ApoAI Is Critical for Lecithin:Cholesterol Acyltransferase-Induced Hyperalphalipoproteinemia and HDL Remodeling in Transgenic Mice Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 459 - 466. [Abstract] [Full Text] [PDF]

				M. N. Nanjee and E. A. Brinton Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography Clin. Chem., February 1, 2000; 46(2): 207 - 223. [Abstract] [Full Text] [PDF]

				B. Foger, M. Chase, M. J. Amar, B. L. Vaisman, R. D. Shamburek, B. Paigen, J. Fruchart-Najib, J. A. Paiz, C. A. Koch, R. F. Hoyt, et al. Cholesteryl Ester Transfer Protein Corrects Dysfunctional High Density Lipoproteins and Reduces Aortic Atherosclerosis in Lecithin Cholesterol Acyltransferase Transgenic Mice J. Biol. Chem., December 24, 1999; 274(52): 36912 - 36920. [Abstract] [Full Text] [PDF]

				G. Lambert, M. B. Chase, K. Dugi, A. Bensadoun, H. B. Brewer , Jr., and S. Santamarina-Fojo Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1 J. Lipid Res., July 1, 1999; 40(7): 1294 - 1303. [Abstract] [Full Text]

				M. J. A. Amar, K. A. Dugi, C. C. Haudenschild, R. D. Shamburek, B. Foger, M. Chase, A. Bensadoun, R. F. Hoyt , Jr., H. B. Brewer , Jr., and S. Santamarina-Fojo Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice J. Lipid Res., December 1, 1998; 39(12): 2436 - 2442. [Abstract] [Full Text]